Widespread contamination of N,N-dimethylformamide (DMF) has been identified in the environment of leather industries and their surrounding residential areas. Few studies have assessed the dose-response relationships between internal exposure biomarkers and liver injury in DMF exposed populations. We assessed urinary N-methylformamide (NMF) and N-acetyl-S-(N-methylcarbamoyl) cysteine (AMCC) and blood N-methylcarbmoylated hemoglobin (NMHb) levels in 698 Chinese DMF-exposed workers and 188 nonDMF-exposed workers using ultraperformance liquid-chromatography tandem mass-spectrometry. Liver injury was defined as having abnormal serum activities of any of the 3 liver enzymes, including alanine aminotransferase, aspartate aminotransferase, and c-glutamyl transpeptidase. Higher liver injury rates were identified in DMF-exposed workers versus nonDMF-exposed workers (9.17% vs 4.26%, P ¼ .029) and in male versus female workers (11.4% vs 3.2%, P < .001). Positive correlations between environmental exposure categories and internal biomarker levels were identified with all 3 biomarkers undetectable in nonDMF-exposed workers. Lower confidence limit of benchmark dose (BMDL) was estimated using the benchmark dose (BMD) method. Within all study subjects, BMDLs of 14.0 mg/l for NMF, 155 mg/l for AMCC, and 93.3 nmol/g for NMHb were estimated based on dose-response relationships between internal levels and liver injury rates. Among male workers, BMDLs of 10.9 mg/l for NMF, 119 mg/l for AMCC, and 97.0 nmol/g for NMHb were estimated. In conclusion, NMF, AMCC, and NMHb are specific and reliable biomarkers and correlate well with DMF-induced hepatotoxicity. NMF correlates the best with liver injury, while NMHb may be the most stable indicator. Males have a greater risk of liver injury than females upon DMF exposure.
N, N-dimethylformamide (DMF) has been widely used in industrial and pharmaceutical productions (Nomiyama et al., 2001a,b) . Human exposure to DMF mainly occurs in occupational settings through inhalation and dermal contact. In 2011, China has >2000 polyurethane synthetic leather industries with a total annual production volume over 0.4 billion square meters and these industries have employed over half a million workers (Qian et al., 2011) . In these industries, DMF air concentration exceeding the national occupational exposure limit (8-h time weighted average [TWA] of 20 mg/m 3 , GBZ2.1, 2007) has been reported (Ministry of Health of People's Republic of China, 2007; Qian et al., 2011) . Recently, DMF of 4.4-678.3 mg/m 3 was also detected in air at some residential areas next to synthetic leather industries in China (Wang et al., 2014) . This level dramatically exceeded the DMF reference concentration of 30 mg/m 3 (life time exposure) set by U.S. Environmental Protection Agency (USEPA, 1999) . Currently, the national standard for DMF concentration in ambient air has not been established in China. Animal and epidemiological studies identified liver injury as an early health effect of DMF exposure (Fiorito et al., 1997; Hamada et al., 2009; Kennedy and Sherman, 1986; Lynch et al., 2003) . The most common liver diseases in DMF-exposed workers include hepatitis, fibrosis, and cirrhosis (Kim and Sang, 2011; Redlich et al., 1988; Scailteur and Lauwerys, 1987) . Animal studies also demonstrated that DMF can cause hepatocellular adenoma and carcinoma through inhalation exposure (Senoh et al., 2004) . DMF has been reclassified as "probably carcinogenic to human" (group 2A) in 2016 based on increasing evidences (IARC, 2016) . Therefore, DMF has been prioritized for field studies because of its severe toxicity, widespread contamination, and wide industrial application. The metabolism of DMF begins with its oxidation to N-hydroxymethyl-N-methylformamide (HMMF) by cytochrome CYP2E1 (Mr az and Turecek, 1987, Figure 1A) . HMMF further breaks down to form N-methylformamide (NMF), which in turn is oxidized to a reactive intermediate most likely methyl isocyanate (MIC) (Threadgill et al., 1987) . MIC can rapidly bind to endogenous nucleophilic sites, including glutathione (GSH) and hemoglobin (Hb), resulting in formation of N-acetyl-S-(Nmethylcarbamoyl)cysteine (AMCC) (Kestell et al., 1986; Mr az and Turecek, 1987, Figure 1B) and N-methylcarbmoylated-hemoglobin (NMHb) (Angerer et al., 1998; Ramachandran et al., 1988 ; Figure 1C ). The series of metabolic reactions may cause function damages of macromolecules, GSH depletion, increased free radicals, and endoplasmic reticulum dysfunction that may contribute to liver toxicity (Kim et al., 2010; Kim and Sang, 2011) . NMF and AMCC in urine and NMHb in blood have been used to evaluate DMF exposure in occupational settings (K€ afferlein and Angerer, 2001; K€ afferlein et al., 2005; Mr az and Turecek, 1987) .
Urinary NMF and AMCC were the most commonly studied biomarkers for evaluating DMF exposure mainly because of easy sampling and less challenge in quantification techniques (K€ afferlein et al., 2000 Nomiyama et al., 2001a; Wang et al., 2007) . American Conference of Governmental Industrial Hygienists (ACGIH, 2001 ) recommends a biological exposure index (BEI) of 15 mg/l for urinary NMF, while Deutsche Forschungsgemeinschaft (DFG, 2016) advises a biological tolerance value (BAT) of 35 mg/l. ACGIH recommends a BEI of 40 mg/l for urinary AMCC (ACGIH, 2016) . Blood NMHb was rarely measured in field studies (K€ afferlein et al., 2005) . No threshold limit value has been established for NMHb and only a reference value of 135 nmol NMHb/g globin was proposed based on toxicokinetics method (Mr az et al., 2002a) . Several studies have suggested a positive relationship between urinary NMF and liver injury (Fiorito et al., 1997; Wrbitzky, 1999) . However, associations between AMCC and NMHb and liver injury have not been established in population studies yet (He et al., 2010) . Moreover, no comparative studies of all 3 biomarkers for risk assessment have been conducted.
An epidemiological study was conducted to assess the environmental and internal DMF exposure (NMF and AMCC in urine and NMHb in blood) and liver injury in 698 DMF-exposed workers from 2 synthetic leather industries and 188 Non DMF-exposed controls. Based on the dose-response relationships, a benchmark dose (BMD) method (Crump, 1986; Haber et al., 1998; USEPA, 2012) was used for the first time to estimate the lower confidence limit of benchmark doses (BMDLs) for NMF, AMCC, and NMHb.
MATERIALS AND METHODS
Study subjects. A total of 698 DMF-exposed workers from 2 synthetic leather factories in Jiangsu province in China and 188 nonDMF-exposed workers from 2 other companies located in the same city without DMF exposure or any other chemical exposure were recruited (Supplementary Table 1 ). DMF-exposed workers were also exposed to louder noise and polyurethane resin though no causal relationships had been established between noise and polyurethane resin and liver injury (Berglund et al., 1999) . The study protocol was approved by the Research Ethics Committee of the National Institute for Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention (China CDC). All participants were fully informed about the study procedure and consented to participate in the study. Demographic information including sex, age, occupational history, alcohol drinking, and smoking was obtained through face to face interview. Individuals who had smoked more than 100 cigarettes in their lifetimes were considered as smokers. Individuals who drank more than twice a week in the last 6 months were classified as alcohol users. Workers who were hepatitis virus carriers or were on any medications within 3 days before biospecimen collections were excluded from this study.
Field survey. The DMF-exposed factories in China mainly manufacture polyurethane synthetic leather. In general, workers at the posts of mixing mix the raw materials containing DMF, and then dissolve the polyurethane resin by DMF. After the materials are homogenized by dispersing homogenizers and extruded on the surface of the base fiber, workers at the posts of coating will adjust the coating thickness and width. Mixing and coating procedures are operated in a semi-enclosed (open at the top) environment that has the highest DMF concentration in air. Workers unreeling base fibers at the beginning or rolling the prepared fibers at the end of the process line, do not use DMF directly at work. But they are still at risk of DMF exposure due to inhalation of evaporated DMF in the air. Other auxiliary posts, such as product inspection, transportation and maintenance also have a risk of DMF exposure. During the field visit, we found that the local forced ventilation and protective half-mask respirator were only used in the posts of mixing and coating. Other working areas in the factory only had general ventilation. Workers did have long-sleeved clothes and impermeable gloves for protection. Administration offices were in a separate building but close to the workshops. Based on the worksites description and the historical data of ambient monitoring at different work posts (Supplementary Table 2 ), DMF-exposed workers in these 2 synthetic factories (E1 and E2) were categorized into 3 groups as follows: group 1 (low exposure), group 2 (moderate exposure), and group 3 (high exposure). Workers in group 1 consisted of 106 subjects working in administration office, sales department, etc. Workers in group 2 consisted of 325 subjects working at the posts of unreeling the base fibers, rolling the prepared fibers, and other auxiliary jobs with an 8-h TWA of DMF exposure between 6.3 and 9.6 mg/m 3 . Workers in group 3 consisted of 267 subjects working at the posts of mixing and coating with an 8-h TWA over 30 mg/m 3 which dramatically exceeded the occupational exposure limit for ambient DMF in workplace in China (20 mg/m 3 , GBZ2.1, 2007).
Chemicals and reagents. All the chemicals and reagents used in sample preparation of urine and blood were analytical grade. DMF (>99.9%, HPLC), NMF (99%), and AMCC (>95%, HPLC) were purchased from Sigma. The standard sample of 3-methyl-5-isopropylhydantoin (MVH) and internal standard of 3-methyl-5-isobutylhydantoin (MIH) were prepared by Hunan Chemical Research Institute in China (Mr az et al., 2002b; Ramachandran et al., 1988) .
Analytical chemistry. Urine samples collected at the end of a working week shift were used to measure NMF and AMCC. Urine sample preparation was performed as described elsewhere (Sohn et al., 2005) . Analysis was carried out by Ultra Performance Liquid Chromatography Tandem Mass Spectrometry (UPLC-MS/MS, Waters, USA). The limit of detection (LOD) was 0.005 mg/l for NMF and 0.2 mg/l for AMCC. Blood samples (5 ml) were collected from all workers and stored in tubes containing heparin as anticoagulant. Red blood cells separated and washed by 0.9% NaCl for 3 times, were lysed with distilled water using sonication. Ice-cold acetone (containing 2% of concentrated HCl) was slowly added in the lysate to precipitate the globin. Then, the globin was washed with ice-cold acetone 3 times and with diethyl ether once, and dried under nitrogen. Dried globin samples were processed using a modified N-alkyl Edman degradation as previously described in Mr az et al. (2002b, 2006) and analyzed by UPLC-MS/MS. For UPLC-MS/MS analysis, the separation was performed on ACQUITY UPLC BEH C 18 (100 Â 2.1 mm, 1.7 lm) using a mobile phase of 0.1% formic acid ( flow rate of desolvation gas, 800 l/h; low (high) resolution of quadrupole, 13.0; Multiple-reaction-monitoring (MRM) mode was used (parameters of MRM in Supplementary 3). A linear relationship was shown in the range of 0.01-1 lmol/l MVH (R 2 > 0.999), with 0.5 lmol/l MIH as the internal standard. Recovery rate was assessed by spiking MVH to Hb from control human blood and average recovery rate was 97.3% (relative standard derivation, 1.7%, n ¼ 6) with the LOD of 10 nmol NMHb/g globin. Measurements below LOD were replaced with half of the LOD. All samples were randomized and analyzed in batches with each batch containing samples from both exposure groups and control group. Researcher for this analysis was blind to the group identification of testing samples.
Defining subjects with liver injury. Blood samples were collected to measure liver enzyme activities during the field study period. Alanine aminotransferase (ALT), aspartate aminotransferase (AST), and c-glutamyl transpeptidase (c-GT) were determined by an Automatic Biochemical Analyzer (Hitachi 7180). The reference value ranges for ALT, AST, and c-GT were 0-45, 0-45, and 8-58 U/l, respectively. Study subjects with any of the 3 enzyme activities greater than the upper limits of the reference ranges were classified as cases with liver injury.
Statistical analysis. All subjects had NMHb and liver enzyme activities (ALT, AST, and c-GT) measured. Among them, 870 subjects (98%), including 682 DMF-exposed workers and 188 Non-DMFexposed workers, had urinary NMF and AMCC data available. Group comparisons were conducted by Student's t test for one continuous variable (age), and by Chi-square test for categorical variables (smoking, alcohol use, sex, and liver injury). Differences of DMF metabolites (NMF, AMCC, and NMHb) among 3 DMFexposed groups (groups 1-3) were evaluated by Kruskal-Wallis test, because the distribution of each group was not normally distributed. NonDMF-exposed workers were denoted as the T0 group, while DMF-exposed workers were grouped into 3 groups (T1-T3) based on tertiles of each DMF biomarker to assess the dose-response relationship. Linear-by-linear association (trend test) was used to assess the dose-response relationships between DMF environmental exposure and biomarker categories and liver injury rate. Logistic regression was used to assess the sex disparity in liver injury with adjustment for DMF exposure levels and history and additional demographic variables. All statistical tests were 2-sided with a significance level of 0.05 and performed using SPSS software (SPSS 19.0, USA).
Benchmark dose estimation. Benchmark Dose Software (BMDS) Version 2.6 from USEPA (USEPA, 2012, 2016) was used to calculate BMD and BMDL associated with a benchmark response (BMR). A BMR of 10% (Wang et al., 2013) above the adverse response rate seen in control group was chosen. The median of NMHb, NMF, and AMCC levels measured in each exposure group (T0-T3 as defined earlier) and corresponding liver injury rates were incorporated into the BMD modeling because the biomarker data within each group was not normally distributed. We also ran the analysis using geometric mean of internal biomarker levels within each group. The BMD method is preferred for establishing reference dose than traditional no-observed adverse effect level-based methods (Crump, 1986; Haber et al., 1998; USEPA, 2012) because BMD method maximizes the use of entire dose-response range.
Comparisons of performance of 3 biomarkers for predicting liver injury. We took the following 2 approaches to compare the performance of 3 biomarkers for predicting liver injury. First, Wilcoxon test was used to compare the biomarker levels between workers with and without liver injury. The biomarker corresponding to the most significant Wilcoxon test was considered as the best biomarker predicting liver injury. Second, indexes of screening test commonly used in epidemiological studies were calculated to compare the performance for predicting liver injury among the 3 biomarkers and between BMDLs estimated in this study and reference dose values from regulation or literature. A series of indexes were calculated, including the number and rate exceeding the reference doses, positive predictive value (PPV), negative predictive value (NPV), sensitivity, specificity, Youden's index, positive likelihood ratio (þLR), negative likelihood ratio (ÀLR) and areas under the receiver operator characteristic curve (AUC) (SPSS 19.0) . Detailed description of these indexes was available in Table 6 . Greater values of PPV, NPV, sensitivity, specificity, Youden's index, þLR, and AUC, or a lower value of -LR indicate better performance of a biomarker for predicting liver injury in this study.
RESULTS

Characteristics of the Study Population
The distributions of age, sex, smoking status, and alcohol use between DMF-exposed and nonDMF-exposed workers were not statistically different (Table 1) . DMF-exposed workers had a mean exposure history of 3.29 years. Liver injury rate was significantly higher in DMF-exposed workers compared with nonDMF-exposed workers (9.17% vs 4.26%, P ¼ .029).
Risk Factors for Liver Injury in DMF-Exposed and NonDMF-Exposed Groups
The effects of age, sex, smoking status, alcohol use, and DMF exposure history (DMF exposed group only) on prevalence of liver injury were assessed in DMF-exposed and nonDMFexposed workers separately (Table 2) . Male DMF exposed workers had significantly higher prevalence of liver injury compared with female workers (11.4% vs 3.2%, P < .001). We further assessed whether the sex disparity in liver injury among DMF exposed workers was due to higher DMF exposure in male versus female workers. The DMF exposure history and the external exposure levels estimated based on the ambient monitoring data for different worksites were compared between male and female workers (Supplementary Table 4) . No significant differences for these 2 exposure parameters were identified (Ps > .53). Logistic regression was used to assess the effect of sex on liver injury with adjustment for exposure duration and exposure levels estimated from worksite descriptions and other important covariates (eg, age, smoking status, and alcohol use). Sex remained statistically significant (OR ¼ 4.5, 95% CI ¼ 1.9-10.8, P ¼ .001) in this model, suggesting sex effect on liver injury was not confounded by these factors in DMF-exposed workers. Liver injury rate was always higher in DMF-exposure workers compared with nonDMF-exposed workers in all subgroup analyses.
DMF Metabolites Levels in DMF-Exposed Workers and NonDMF-Exposed Workers As shown in Figure 2 , median values of NMF and AMCC in urine and NMHb in blood in DMF-exposed workers were 1.75 mg/l, 44.09 mg/l, and 46 nmol/g globin, respectively, while all 3 DMF biomarkers were undetectable in nonDMF-exposed workers. In addition, among DMF-exposure workers, good correlations between environmental exposure categories and levels of internal exposure biomarkers were identified with group 3 having the highest and group 1 having the lowest levels of biomarkers (Table 3 ). Significant correlations were identified in DMF-exposed workers between NMF and AMCC (r ¼ 0.291, P < .001), between AMCC and NMHb (r ¼ 0.631, P < .001), and between NMF and NMHb (r ¼ .403, P < .001).
The Relationships Between DMF Exposure and Liver Injury Rate A significant dose-response trend in liver injury rates was identified among the 4 environmental exposure groups (P < .001) categorized based on worksites (Table 4) . When workers were classified into 4 groups (T0-T3) based on levels of NMF, AMCC, and NMHb, significant dose-response trends were identified as well with P value < .001 for NMF, and P values of .007 and .004 for AMCC and NMHb, respectively (Table 4) . Because a sex disparity in liver injury was observed in DMF-exposed workers, additional analysis was conducted in male workers only due to sufficient sample size to assess the association between DMF exposure and liver injury. NonDMF-exposed male workers were denoted as the D0 group, while DMF-exposed male workers were divided into 2 groups (D1 and D2) based on the median levels of biomarkers observed in male DMF-exposed workers. Significant dose-response trends were identified for liver injury rate across the 3 groups with P values of .001, .031, and .003 for NMF, AMCC, and NMHb, respectively (Supplementary Table 5 ). Similar analysis in female workers was not conducted due to limited sample size.
Estimation of BMDLs for NMF, AMCC, and NMHb
As shown in Table 4 , good dose-response relationships were identified between median NMF, AMCC, and NMHb concentrations and liver injury rates, supporting the potential causal relationship between DMF exposure and liver injury. Table 5 summarized the model fitness parameters for the 6 models and the BMD and BMDL calculated. The ranges of BMDLs from all the models were 9.83-14.0 mg/l for NMF, 155-276 mg/l for AMCC, and 92.8-154 nmol/g globin for NMHb. According to methods described in BMDS analysis reference (USEPA, 2012), BMDLs from the models with best fitting for NMF, AMCC, and NMHb were 14.0 mg/l, 155 mg/l, and 93.3 nmol/g globin, estimated from Quantal-linear model, Log-logistic model, and Log-logistic model, respectively (Table 5 and Supplementary Figs.1-3) . We also ran the analysis using geometric mean of internal biomarker levels within each group. The BMDLs for all 3 biomarkers across 6 models (Table 5) are only slightly higher than the BMDLs calculated using median values from each exposure group. Because male workers had a higher risk of liver injury than female workers, the BMDLs values for male workers were also calculated and BMDLs from models with the best fitting were 10.9 mg/l, 119 mg/l, and 97.0 nmol/g for NMF, AMCC, and NMHb, respectively (Supplementary Table 6 ). Similar analyses were not performed in females due to limited sample size.
Comparisons of Performance of Three Biomarkers for Predicting
Liver Injury P values of Wilcoxon test for NMF, AMCC, and NMHb between DMF exposed workers with and without liver injury were 0.001, 0.054, and 0.043, respectively, indicating NMF as the best biomarker for predicting liver injury. Indexes of screening test are shown in Table 6 . In this study, NPVs of all DMF biomarkers were similar, while PPV of NMF was higher than seen for AMCC and NMHb, suggesting NMF as a more efficient biomarker for predicting liver injury than AMCC and NMHb. Similarly, Youden's index and þLR value were higher for NMF compared with AMCC or NMHb, further supporting NMF as the most accurate DMF biomarker for predicting liver injury. Similar analyses conducted in male DMF-exposed workers identified NMF as the best biomarker predicting liver injury as well (not shown). 
DISCUSSION
This is the first large-scale BMDL study conducted in DMF exposed populations with liver injury as the outcome. A significantly higher liver injury rate was identified in DMF-exposed workers compared with nonDMF-exposed workers, supporting liver as the primary target organ of DMF toxicity. We also found NMF, AMCC, and NMHb were specific biomarkers for DMF exposure because they were not detectable in nonDMF-exposed workers. However, it was worth noting that NMF, AMCC, and NMHb were also detectable in administration staff and sales persons categorized in the low DMF-exposed group who did not work in the workshops. This was probably because these workers may visit workshops occasionally or DMF may contaminate the air surrounding the factories. Based on dose-response relationships, we obtained reliable evidences linking NMF, AMCC, or NMHb to liver injury and estimated BMDLs of 14.0 mg/l for NMF, 155 mg/l for AMCC, and 93.3 nmol/g for NMHb, respectively.
We further compared threshold limit values of DMF biomarkers from regulation or literature and BMDLs from this study. For NMF, 15 mg/l from ACGIH (2016) was very close to BMDL of 14.0 mg/l in our study. For NMHb, 135 nmol/g from the literature (Mr az et al., 2002a) was higher than the BMDL of 93.3 nmol/g estimated in our study. However, we observed a large difference for AMCC between 40 mg/l from ACGIH (2016) and the BMDL of 155 mg/l estimated in our study. There were several reasons for the differences between AMCC or NMHb reference doses reported in previous studies and those estimated in our study. First, the meaning of threshold limit value which is a value below some threshold of effect is different from that of BMDL which is a 1-tail 95% lower bound on the BMD associated with a BMR of 10% above the adverse effect in controls. Second, the methods to obtain threshold limit values of AMCC and NMHb are different from BMD methods used in this study. Previous, the BEI of AMCC (ACGIH, 2001 (ACGIH, , 2016 ) was a conservative estimated value from small-scale field studies (He et al., 2010; Sakai et al., 1995) while the BMDL of AMCC was estimated based on the dose-response relationship in our study. The reference dose of NMHb from volunteer study or toxicokinetics method was estimated under controlled conditions (Mr az et al., 2002a) , while our study was in real occupational settings and based on BMD methodology. Third, some studies showed even within the same exposure group, urine AMCC fluctuated or varied in a wider range compared with NMF (He et al., 2010; Tsuda et al., 2014) . Ethnic disparity was probably a fourth reason for such discrepancy. CYP2E1 is the major enzyme for DMF metabolism. Some functional single nucleotide polymorphisms (SNPs) of CYP2E1 exhibit large differences in minor allele frequency (MAF) in different populations. For example, the MAFs of SNPs (rs3813867 and rs2031920) associated with increased hepatocarcinogenic risk (NCBI, 2013a,b; Zhang and Gu, 2003) and the SNP (rs6413431) associated with alcohol-related hepatic disease (Verlaan et al., 2004) exhibit differences between Asians and Caucasians (Wang et al., 2009) . Therefore, BMDLs of NMF, AMCC, and NMHb derived in this study may be more suitable for occupational populations with genetic background similar to Han Chinese. If BMDLs derived from our study were going to be used for another population, ethnic differences in DMF metabolism should be considered. Both Wilcoxon test results and indexes from screening tests suggest that NMF is probably the biomarker that best correlates with liver injury among 3 DMF biomarkers examined. In addition, we can also compare the sensitivity between NMF and AMCC directly, because they are both urinary biomarkers. By transforming the unit of mg/l to mmol/l, our estimated BMDL for NMF (0.238 mmol/l) is lower than our estimated BMDL for AMCC (0.877 mmol/l), which indicates that NMF is a more sensitive endpoint than AMCC based on liver injury. However, the sensitivity of NMF or AMCC cannot be compared directly with that of NMHb because they are detected in different human compartments.
Though NMF was considered as the biomarker correlated best with liver injury in this study and urinary biomarkers could be more easily conducted, NMHb retains some advantages due to its long half-life leading to flexibility in sampling time. For NMF, elimination half-lives are 2.42 and 4.75 h (Nomiyama et al., 2001a) for lung and skin exposure, respectively. The sampling time for NMF is rigid (postshift urine). NMF cannot reflect the accumulative exposure. With elimination half-life of 22.1 h (Casal Lareo et al., 1995) or 23 h (Mr az and Nohov a, 1992), AMCC is used to assess the cumulative DMF exposure over a week. However, ACGIH recommends a BEI of 40 mg/l for AMCC measured in urine only collected at the end of the shift at the end of the workweek (ACGIH, 2001) or prior to the last shift of a workweek (ACGIH, 2016) to be reflective of exposure during the week. NMHb persists in the human body for a much longer period (>120 days). Thus, unlike NMF and AMCC, the sampling time for NMHb is quite flexible and any time point within the 4-month period post DMF-exposure should work. Therefore, among 3 DMF biomarkers, NMHb is the most stable indicator.
Due to the fast elimination of NMF or AMCC from body in 1 day or 1 week, the stability of NMHb is very important in some scenarios for risk assessment. For example, during episodic or irregular production seasons in factories, or for workers recently losing their jobs, or office staff visiting workshops occasionally, or residents living around factories, the detection of NMHb typically can trace DMF exposure for these people for up to 4 months ago, while NMF or AMCC may become undetectable a few days or weeks postDMF exposure. In fact, there were 5 workers with abnormal liver enzyme activities who had NMF levels lower than 14.0 mg/l (BMDL for NMF), but had NMHb levels higher than 93.3 nmol/g (BMDL for NMHb). Therefore, risk assessors should select suitable DMF biomarkers to apply based on the actual scenario. This is the first report of a sex disparity in liver injury in a large sample size of DMF-exposed workers. Male workers had 4.5-fold increased prevalence for liver injury compared with female workers and this result was consistent with animal studies. Male rats and mice exposed to DMF for 13 weeks or 
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2 years were more likely to have increased liver weights and hepatocarcinogenicity than female animals (Senoh et al., 2003 (Senoh et al., , 2004 . Several factors may contribute to the sex disparity of DMF-induced liver injury in human subjects, including DMFexposure levels, CYP2E1 activity, alcohol use, and GSH levels. As mentioned in the results, sex differences were not simply due to male workers having higher exposures than female workers. CYP2E1 activity is positively associated with production of the intermediate DMF metabolite (MIC) which is closely related to liver injury. Previous studies have reported elevated CYP2E1 activity in men than in women based on human hepatic gene expression (Tanaka, 1999; Yang, 2011) , indicating more MIC production in males than females. Previous studies also showed alcohol affects DMF metabolism by inducing CYP2E1 activity (Johansson et al., 1988) . In our study, significantly higher alcohol use was observed in males than females (P < .001) (Supplementary Table 4 ), which may further increase CYP2E1 activity in males. GSH levels in males and females were not significantly different (Michelet et al., 1995) . Thus, elevated CYP2E1 activity and more common alcohol use among male workers in our study may contribute to higher prevalence of liver injury in male compared with female workers.
In conclusion, our study showed NMF, AMCC, and NMHb were reliable and specific biomarkers of DMF exposure and revealed dose-response relationships between their levels and liver injury. We obtained BMDLs of 14.0 mg/l for NMF, 155 mg/l for AMCC, and 93.3 nmol/g for NMHb. Male workers had a higher risk of liver injury than female workers. As starting points for regulatory efforts to help decrease the risk of liver injury for DMF-exposed male workers, we estimated BMDLs of 10.9 mg/l for NMF, 119 mg/l for AMCC, and 97.0 nmol/g for NMHb in male workers. NMF and AMCC (especially NMF) are recommended for periodic biomonitoring of occupational health. NMHb is the most stable indicator, which is recommended to trace intermittent DMF-exposure every 4 months. Therefore, investigators should select the most suitable DMF biomarkers based on the characteristic of each biomarker for specific occupational exposure situations.
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